HDAC9 and myeloid leukemia: An analysis of Down syndrome-associated myeloid leukemia cell lines showed that HDAC inhibitors suppress autophagy by increasing the acetylation of autophagy-related proteins such as ATG7 and exhibit autotoxic activity against cells with low autophagic activity [41].